Highlights The first incretin hormone, gastric inhibitory peptide, was identified in the early 1970s, followed by the discovery of glucagonlike peptide 1 (GLP-1) in the 1980s [1]
For a 1 mg daily dose: Volume = 1 mg / 25 mg/mL = 0.04 mL = 4 units That is a very small draw
doi:10.7326/0003-4819-143-3-200508020-00006
Or Yours
How long does it take to see results from GHK-Cu injections
Further arguments might include modulatory effects on the NO system (NO releasesBPC 157 induced the NO release on its ownparticular effect on NOS inhibition (i.e., opposed hypertension and pro-thrombotic effect of L-NAME) and particular effect on NO over-stimulation (i.e., opposed hypotension and anti-thrombotic, pro-bleeding effect of L-arginine) [39,40,41,42,43,44] controlling vasomotor tone and the activation of Src-Caveolin-1-eNOS pathway [48,49])